Gorwood P
Université Paris Cité , Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, “Vulnerability of Psychiatric and Addictive Disorders” Team
ArticleKetamine
Esketamine-induced dentate gyrus plasticity in treatment resistant depression: first-in-human evidence
ArticleKetamine
Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report.
ArticleKetamine
Trajectory of response to esketamine nasal spray for treatment resistant depression: Findings from ESCAPE-TRD.
PreprintKetamine
Mystical Experience Induced by Esketamine Treatment: A Real-World Observational Study
ArticleKetamine
Is there an independant anti-suicidal effect of esketamine in treatment resistant depression?
ArticleKetamine
Outcomes with esketamine nasal spray in patients with or without earlier partial or full response: post hoc analyses of ESCAPE TRD
ArticleKetamine
Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression.
ArticleKetamine
Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions.
ArticleKetamine